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Despite the success of antibiotic discovery, infectious diseases remain the second leading source of death worldwide, while the
resistance to antibiotics is among the significant problems in the twenty-first century. Medicinal plants are very rich in
phytochemicals which can be structurally optimized and processed into new drugs. Nigeria enjoys a diverse collection of
medicinal plants, and joint research has ascertained the efficacy of these plants. Plants such as guava (Psidium guajava), ginger
(Zingiber officinale), neem (Azadirachta indica), and moringa (Moringa oleifera) have been found to exhibit broad range of
antimicrobial activities. Studies on Nigerian plants have shown that they contain alkaloids, polyphenols, terpenes, glycosides,
and others with possible therapeutic potentials. +e antimicrobial activities of some new compounds such as alloeudesmenol,
hanocokinoside, orosunol, and 8-demethylorosunol, identified from medicinal plants in Nigeria, are not yet explored. Further
investigation and optimization of these compounds will facilitate the development of new sets of pharmacologically acceptable
antimicrobial agents. +is review study revealed the efficacy of medicinal plants as an alternative therapy in combating and
curtailing the development and survival of multidrug-resistant pathogens coupled with the toxic effects of some antibiotics.
Due to enormous therapeutic possibilities buried in medicinal plants, there is a need for more research into unique fingerprints
and novel compounds that can provide cure to the neglected tropical diseases (NTDs) of humans and animals facing Africa,
especially Nigeria.
1. Introduction
Infectious diseases have been consistently found to be
among the leading causes of threat to global health. +e
World Health Organization (WHO) in 2013 reported that
infectious diseases accounted for 61.7% (5.9 million) of the
9.6 million deaths in the sub-Saharan African region. Plants
with medicinal value have found application in healthcare
from the olden years. Globally, there are evidence-based
studies to verify the efficacy of medicinal plants, and some of
these shreds of evidence have provided insights into the
synthesis of plant-based compounds with therapeutics ap-
plication [1]. +e annual global market value of medicinal
plant products has exceeded $100 billion [2].
+e “traditional or herbal medicines” are those origi-
nating from plant sources and are generally regarded as safe
(GRAS) at the concoction dosage, based on their historical
usage in various cultures [3]. +us, plants remain the most
abundant natural primary source of active drugs and are
invaluable in the ethnomedical treatment of diverse ailments
[4]. Medicinal plants are generally sources of various phy-
tochemicals, some of which are usually responsible for their
biological activities.
Traditional medicine as defined by the World Health
Organization is the total of the knowledge, skills, and
practices based on the theories, beliefs, and experiences
indigenous to different cultures, whether explicable or not,
used in the maintenance of health as well as in the
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prevention, diagnosis, improvement, or treatment of
physical and mental illness. However, traditional, comple-
mentary medicine in Nigeria continues to thrive as it is
commonly practised in other African nations as well as in
Asia. Application of ethnomedicinal knowledge in the fields
of biosciences for investigation of novel bioactive com-
pounds as well as the polypharmacological formulation of
plant extracts for use in primary healthcare has been the
central interest in research [5].
Phytochemical screening of the medicinal plants is
usually done against broad spectrum of microorganisms to
ascertain their antimicrobial activities, based on the active
constituents of the plants that are primarily secondary
metabolites. +e present occurrence of antimicrobial drug
resistance by most bacteria has posed an enormous problem
[6] and triggered the need for continuous research for better
and safe therapeutic agents.
Most of the plants that found application in ethno-
medicine have been documented based on their prom-
ising activities against multiple disease-causing
microorganisms [7, 8]. Research efforts are expediting
for better functional understanding of medicinal plants,
and this has provided a model for about 25–50% of the
marketed drugs [9]. Antimicrobial activities of useful
plants vary; the majority act in synergy [10], reducing the
side effect of synthetic drugs [11], while others act as
quorum quenchers [12].
Moreover, this review summarized the salient infor-
mation on the antimicrobial activity of medicinal plants in
Nigeria and provided new bioactive components. +is re-
view explored research works on medicinal plants origi-
nating from Nigeria, and it highlights the constituents with
potential therapeutics activities relevant to the treatment of
microbial infections. +e focus of this work is limited to the
inhibitory effects of phytochemicals on diseases of microbial
origin.
2. Phytochemical Constituents of
Medicinal Plants
Medicinal plants contain bioactive organic chemical com-
pounds often referred to as phytochemicals, which play a
defensive role against major chronic diseases in both host-
metabolic or genetic dysfunctional disease and infectious
disease, and found in grains, vegetables, fruits, and other
plant products [13–16]. Phytochemicals perform interme-
diary metabolic activities, and they function as primary
metabolites such as fats and sugars found in all plants, while
secondary metabolites are found in a smaller range of plants
and provide specialized functions.
Secondary metabolites are biomolecules produced for
sustainability or adaptation of plants in the environment as a
result of many factors, such as protection from drought,
pollination, and predation, but are not required for im-
mediate survival of the plants [17]. Secondary metabolites
and pigments, because of their healing effects in humans are
processed into drugs such as inulin (dahlias plant), mor-
phine and codeine (poppy plant), quinine (cinchona plant),
and digoxin (foxglove plant) [18].
Screening of chemical composition of medicinal plants
revealed that they contain different bioactive compounds
which include saponins, tannins, and alkaloids [19]. +e
main functional classes of phytochemicals with therapeutic
potential include antioxidants, anticancer agents, immunity-
potentiating agents, detoxifying agents, and neuropharma-
cological agents [17]. As shown in Figure 1, each of the
functional classes of the phytochemicals consists of a wide
range of compounds at varying potency and sometimes with
multiple functions [16]. Plants produce unique arrays of
phytochemicals that frequently belong to existing bio-
chemical motifs [20]. Among the bioactive compounds,
triterpenoids provide anti-inflammatory activity and tan-
nins possess astringent, anti-inflammatory, and antimicro-
bial activity properties [21]. Saponins often have medicinal
features as blood cleansers, expectorants, and antibiotics. At
the same time, alkaloids have significant effects on the
central nervous system (CNS), and glycosides are known for
their ability to increase the forces of systolic concentration
[22].
2.1. Phytochemical Screening. +e active ingredients of
medicinal and aromatic plants extracts are in the roots,
stems, bark, leaves, or flowers [17]. Most times, the actions of
these active ingredients on the human CNS could be as-
sociated with ecological roles or biochemical identities in
other plants and higher animals [23]. +e significant steps to
utilize these biologically active compounds from plant re-
sources involve the extraction, primary screening, isolation,
purification, and characterization as well as pharmacological
and toxicological analyses [24].
Pharmaceutically, the extraction involves the separation
of constituents of plant and microorganism tissues using
selective buffer solution or solvents according to standard
protocols [25, 26]. +e crucial parameters that can influence
the quality of an extract from the plant include parts used as
a sample (leaf, bark, or root), solvent and its concentration
used for extraction, and extraction method, while the effect
of chemical constituents obtained from the extract depends
on the nature of the plant material, its source, the extent of
processing, and level of moisture, as well as particle size [27].
Factors that can influence the secondary metabolite com-
position and quantity in an extract include type and time of
extraction, nature and concentration of the solvent, pro-
cessing temperature, and polarity of analytes [27].
Different techniques, which include varieties of column
chromatography, gas chromatography-mass spectrometry
(GC-MS), Fourier-transform infrared spectroscopy (FTIR),
ultraviolet (UV) spectrophotometry, and nuclear magnetic
resonance (NMR), are often used stepwise for purification,
identification, and structural characterization of various
groups of phytochemical compounds in plants extracts
[22, 24, 28].
2.2. Effect of Processing on Phytochemicals. +e processing of
medicinal plants can alter antioxidant activity by increase or
decrease in efficacy. Methods of processing of medicinal
plants can impact on the phytochemical constituent
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availability for pharmacological effect. Baba and Onanuga
[29] found that different methods of processing sandpaper
leaf (Ficus exasperata) extracts inhibited arginase and an-
giotensin-1-converting enzymes (ACE) activities in a dose-
dependent manner. Moreover, their result showed that the
soaking method produced significantly higher inhibition of
both enzymes than other methods which include hand
maceration, boiling, and blending. Previous studies show
that the health benefits of the medicinal plant in mono- or
poly-formulations are often a result of complex mixtures of
phytochemicals in a holistic form which synergistically
modulates multiple targets to produce overall therapeutic
actions due to combined antioxidant properties [30–32].+e
effects of processing methods (blanching, cooking or ther-
mal processing, dehydration or drying, extrusion, and ir-
radiation), other nonthermal processing (storage, carbon
dioxide treatment), and other ingredients in the formulation
on the phytochemicals have been extensively reviewed by
[15]. However, during processing, naturally occurring an-
tioxidants often undergo degradation such as Strecker
degradation, as well as reactions such as Maillard reaction,
leading to the formation of new compounds with lower or
higher antioxidant activity, thereby accounting for the dif-
ferences in the total phenolic contents and antioxidant
activities in the processed when compared to unprocessed
foods [33].
3. Medicinal Plants in Nigeria with
Antimicrobial Activities
Despite the success of antibiotic discovery, infectious dis-
eases are consistently ranked second among causes of death
worldwide [34]. +e pursuit of new compounds that have
therapeutic potential for infectious diseases with no existing
remedy such as Lassa fever and others focuses mainly on
plants as the best reservoir of drug compounds (Table 1).+e
microbial resistance to antibiotics is among the significant
problems in the twenty-first century and has necessitated the
need for a continuous search for more potent and safe
therapeutic agents [7].
3.1. Antibacterial Activity. Tuberculosis (TB) is a life-
threatening disease caused by various Mycobacterium
species and has been ranked among the leading causes of
human death in the developing nations [51]. In 2013,
WHO reported that approximately 8.6 million people
incurred TB and 1.3 million died from it, with an esti-
mated 450,000 new cases of multidrug-resistant TB
worldwide. Chronic cough is a feature of many common
respiratory diseases with the percentage of global oc-
currence in Oceania (18.1%), Europe (12.7%), America
(11.0%), Asia (4.4%), and Africa (2.3%) [52]. Diarrhea is
a killer disease; according to 2015 observatory data of
WHO, the occurrence of childhood mortality in devel-
oping nations due to diarrhoeal disease was between 9%
and 34%. Many enteric bacterial pathogens are re-
sponsible for diarrhea, which include bacteria such as
Vibrio cholera, Campylobacter jejuni, Helicobacter pylori,
Salmonella typhi or paratyphi, Shigella flexneri, Clos-
tridium difficile, and Shiga toxin-producing Escherichia
coli.
Findings of [53, 54] stated that the root and leaf
extracts of Terminalia glaucescens show appreciable ac-
tivity against E. coli and S. typhi [53]. +e methanol
extracts of three Nigerian medicinal plants have anti-
microbial activity against five clinical bacterial isolates
comprising two Gram-positive bacteria (Bacillus subtilis
and Staphylococcus aureus) and three Gram-negative
bacteria (Pseudomonas aeruginosa, E. coli, and Klebsiella












































Figure 1: Classification of phytochemicals adapted from [15].
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of bark of Azadirachta indica (A. Juss.), at a concen-
tration of 25–400 mg/ml, showed significant antibacterial
activity on all 14 strains of multidrug-resistant Salmo-
nella typhi with zone diameter of 18–31mm [55].
An investigation of the activity of aqueous and ethanolic
extracts of Zingiber officinale and Allium sativum extracts on
selected foodborne pathogens (Salmonella species, Bacillus
cereus, E. coli, and S. aureus) showed multidrug resistance.
E. coli was sensitive to aqueous extracts, but S. aureus and
Salmonella species were sensitive to ethanol extracts [56].
+e alcoholic extracts from the leaves of two Diospyros spp.
(D. barteri andD.monbuttensis) showed potent antibacterial
activity against a wide range of Gram-positive and Gram-
negative bacteria, while two fungal species investigated in the
study, Aspergillus niger and Candida albicans, were resistant
to the extracts of both Diospyros spp. [57].
+e result of in vitro study of water, methanol, chloroform,
and petroleum ether extracts of Senna alata flowers, which
examined antimicrobial properties at a final concentration of
500μg/mL, showed antimicrobial activities against clinical iso-
lates of S. aureus, C. albicans, E. coli, Proteus vulgaris, P. aer-
uginosa, andB. subtilis [58].Heeria insignisO.Ktze, amember of
the familyAnacardiaceae, is an indigenousAfrican shrub used in
the treatment of diarrhea, schistosomiasis, and venereal diseases.
+e methanol and dichloromethane extracts of the leaves of H.
insignis possessed antibacterial and antidiarrheal activities, while
methanol showed a more significant antibacterial activity than
dichloromethane [59]. However, aqueous extracts of the stem
bark of Spondiasmombin have outstanding anthelmintic activity
at low concentrations [3].
Preliminary investigation of the in vitro vibriocidal ac-
tivities of three medicinal plants (traditional Ogi-tutu, Psi-
dium guajava, and Vernonia amygdalina), using agar cup
diffusion assay, showed that V. amygdalina has the highest
ameliorative effects in the deterrence and cure of V. cholerae
infection [60]. Moreover, a study has revealed the anti-
bacterial property of T. vulgaris on multiple antibiotic-re-
sistant Vibrio fluvialis and Vibrio parahaemolyticus isolated
from shrimps using agar diffusion method [61]. +e ex-
amination of Argemone mexicana L. for antimicrobial ac-
tivity showed that the aerial and root extracts inhibited B.
subtilis and K. pneumoniae, but P. aeruginosa and S. aureus
were not prone to the aerial and root extracts.
In Nigerian ethnomedicine, Annona senegalensis Pers.
(Annonaceae) has been used for the treatment of infectious
diseases. Okokon et al. [62] investigatedA. senegalensis using
the GC-MS and agar-well-diffusion method and found that
lipophilic fraction and kaurenoic acid from A. senegalensis
root bark showed potent antibacterial activity. Furthermore,
the results of in vivo and in vitromodel investigations of the
antidiarrheal properties of the stem bark extract of A.
senegalensis using mice and isolated rabbit jejunum showed
maximum inhibition at a dose of 10mg/kg. At the same
time, intestinal transit time decreased at concentrations of
0.2–3.2mg/ml, and the extract lessened spontaneous con-
tractions of the jejunum [63].
Ficus exasperataVahl-Holl (Moraceae) leaves inWest Africa
are used for the treatment of infectious diseases and inflam-
matory conditions. However, a more thorough phytochemical
analysis of the ethnomedicinal uses of F. exasperata has iden-
tified new compounds: apigenin C-8 glucoside, isoquercitrin-6-
O-4-hydroxybenzoate, and quercetin-3-O-β- rhamnoside, as
some of the constituents of this plant that inhibited the growth of
Gram-positive organisms only [64].
3.2. Antimalarial Activity. Malaria, a significant threat to
global health, is responsible for the death of millions of
people predominantly in sub-Saharan Africa. +e occur-
rence of multidrug-resistant malaria parasites has triggered
efforts to develop combined formulations (such as arte-
mether-lumefantrine and sulfadoxine-pyrimethamine) and
continuous research toward discovering better therapeutics.
An in vitro study by Oladele [65] on the sensitivity pattern of
Plasmodium falciparum to Diospyros monbuttensis (“Egun
eja”), Momordica charantia (“Ejirin”), and Morinda lucida
(“Oruwo”) recorded the lowest antiplasmodial activity with
the ethanolic extract of M. lucida (IC50 � 25 nM) while D.
monbuttensis recorded the highest activity (IC50 � 3.2 nM).
A study on the anticoccidial effect of M. lucida on
Eimeria parasites has suggested its potential as an anti-
coccidial drug for veterinary purposes, especially the poultry
birds [66]. Furthermore, the triterpenes and phytosterols
derived fromM. lucida showed high binding affinity toward
the selected histone deacetylases (class I HDAC and HDAC7
isoforms) and exhibited good druggable characteristics [67].
Table 1: Summary of selected antimicrobial medicinal plants in Nigeria.
SN Botanical name of the medicinal plant Major therapeuticapplication References
1
Argemone mexicana, Ficus exasperate, Persia Americana, Alchornea laxiflora, Crinum
jagus, Adansonia digitate, Citrullus colocynthis, Cola nitida, Dorstenia prorepens,




Enantia chlorantha, Azadirachta indica, Justicia flava, Landolphia owariensis, Cassytha
filiformis, Morinda lucida, Allamanda cathartica, Allophylus africanus, Clerodendrum
capitatum, Bixa Orellana, Senna alata
Antibacterial antiparasitic
antifungal [35, 37, 40–43]
3
Mangifera indica, Myristica fragrans, Cajanus cajan Gossypium arboretum,
Amaranthus spinosus, Heeria insignis, Momordica charantia, Diospyros monbuttensis,
Morinda lucida, Calotropis procera
Antiparasitic [35, 37, 44, 45]
4 Ageratum conyzoides, Macaranga barteri, Mondia whitei Antiviral [46–50]
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Oladele [65], investigated the antiplasmodial activity of
crude n-hexane and ethanolic extracts of M. oleifera seeds
using the cold extraction method and found the highest
parasite inhibition activity in crude ethanolic extract. Be-
sides, Landolphia owariensis P.Beauv., a member of the
family Apocynaceae, is used in southeast Nigeria for the
treatment of malaria. A study has shown that methanol
fractions of L. owariensis leaf in early, established, and re-
sidual infections in Plasmodium berghei-infected albino
mice have the most significant antiplasmodial activity in all
the models carried out, due to alkaloids, flavonoids, sapo-
nins, and tannins present in the fractions [68].
Allamanda cathartica and Bixa orellana are antimalarial
plants [69]. Moreover, Alchornea laxiflora (Benth.), a
member of the family Euphorbiaceae, is used traditionally in
the treatment of malaria in Nigeria. Furthermore, the study
has shown that root extract A. laxiflora exerted significant
antimalarial activity against P. berghei infection while ethyl
acetate fraction exerted the highest activity against chloro-
quine-sensitive (Pf3D7) and -resistant (PfINDO) strains of
P. falciparum infection in mice [70]. Enantia chlorantha has
significant utilization in traditional medicine for the treat-
ment of several diseases which include malaria. However,
another study has suggested that oral administration of E.
chlorantha at relatively high doses may produce severe toxic
effects [71]. A study on the acute and subacute toxicity of the
medicinal plant E. chlorantha carried out in mice showed a
mean lethal dose (LD50) of 0.7 g·kg−1 for ethanolic but
43.65 g·kg−1 for aqueous preparations [72].
Cajanus cajan (L.) is a member of the family Fabaceae
and possesses antimalarial properties. +e result of the in
vitro investigation of crude methanolic extract of C. cajan
leaves, using the multiresistant strain of P. falciparum (K1)
and combination of chromatographic techniques, identified
cajachalcone (2′,6′-dihydroxy-4-methoxy chalcone) from
the ethyl acetate fraction, as one of the biologically active
constituents [73].
Azadirachta indica (A. Juss.) belongs to the family
Meliaceae, which is a common plant especially in Africa, and
extracts from parts of this plant have shown pharmaco-
logical activities which include antiplasmodial activity [74].
However, the antimalarial activity of A. indica is yet to be
fully ascertained, this calls for in-depth research on anti-
malarial activity of A. indica. However, an in silico study [75]
has identified margolonone, nimbinone, and nimbione as
the highest functional compounds that can modulate the
activity of P. falciparum heat shock protein 90 (PfHsp90).
Research has shown that Allophylus africanus extracts
curbed parasitemia caused by intraperitoneal administration
of erythrocytes of P. berghei (NK-65) in mice, and it was
found that flavonoids, saponins, tannins, and carbohydrates
are predominant in all parts of A. africanus [76]. Moreover,
four new compounds, hanocokinoside, allotaraxerolide,
alloeudesmenol, and alloaminoacetaldehyde, have been
identified as some of the chemical constituents of A. afri-
canus [42]. +ree lignans, (+) isolariciresinol, helioxanthin,
and justicinol, have been isolated from Justicia flava VAHL
leaves [77]; in addition, 8-demethylorosunol and orosunol
were reported as two new 1-aryl-2, 3-naphthalide lignans
from J. flava root [78]. +erefore, further investigation and
optimization of these new compounds can help in the design
and production of a new set of efficacious and safe anti-
microbial agents.
3.3. Antifungal Activity. Infections caused by fungi are
termed fungal infections or mycoses. Fungal infections have
been considered a serious health problem and life-threat-
ening diseases in recent years, especially in immunodefi-
ciency conditions [8, 79]. Severe fungal diseases result from
other health challenges such as human immunodeficiency
virus (HIV), asthma, cancer, organ transplantation, and
corticosteroid treatments [80]. In Nigeria, fungal infections
(cryptococcal antigenemia, subclinical histoplasmosis) have
been implicated in HIV/AIDS patients and neonatal in-
tensive care babies [81, 82]. In Cameroun, esophageal
candidiasis, cryptococcal meningitis, Pneumocystis pneu-
monia, disseminated histoplasmosis, and invasive asper-
gillosis were prevalent in adults, while tinea capitis was
prevalent among school children ([83]. In Mozambique,
disseminated Emergomyces and recurrent Candida vulvo-
vaginitis were common among HIV patients [84]. Some
hospitalized patients are at risk of contracting fungal in-
fections [85]. Besides, emerging and reemerging fungal
infections due to recent therapies for autoimmune and
cancer-related diseases (hematopoietic stem cell transplant)
are becoming public health concern [86, 87]. Different parts
of Calotropis procera, a flowering plant that belongs to the
family Asclepiadaceous, have been utilized in traditional
medicine for the treatment of infections which include
eczema, cutaneous infections, leprosy, and syphilis, as well as
malaria. In a study on antifungal activity of C. procera, there
was complete inhibition of Microsporum and Trichophyton
species after ten days of inoculation with water extract at
different concentrations [88].
Crude methanolic extract of Spondias mombin (bark and
leaves) was found to exhibit anticandidal effects with di-
ameters of 11.00± 0.47mm and 15.00± 0.47mm, respec-
tively. +e extracts have varying degrees of phytochemical
compositions such as terpenoids, alkaloids, glycosides, sa-
ponin, and flavonoids [89]. Psidium guajava extracts were
active on Candida albicans isolates from caries infected
patients [90]. Additionally, Alchornea laxiflora leaf extracts
have antibacterial and antifungal activities due to flavonoids,
alkaloids, saponins, tannins, and reducing sugars as major
phytochemicals [36].
3.4.AntiviralActivity. Human immunodeficiency virus type
1 (HIV-1) encodes reverse transcriptase which functions in
the process of the viral genome reverse transcription, a
fundamental step in the HIV-1 replication cycle and
promising target in the antiretroviral drug development
[91]. A study conducted in Nigeria [47] on the antiviral
activities of 27 medicinal plant extracts, belonging to 26
different plant species, against echovirus 7, 13, and 19 se-
rotypes (E7, E13, and E19, respectively) revealed the highest
antiviral activity from methanolic extract of Macaranga
barteri leaves on E7 and E9, respectively, followed by
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Ageratum conyzoides leaves extract on E7 and E19 and
Mondia whitei leaves extract on E7 and E19. In China,
Rheum palmatum and Rheum officinale extracts along with
their main single isolated constituents’ anthraquinone de-
rivatives inhibited both HIV-1 reverse transcriptase-asso-
ciated DNA polymerase (RDDP) and ribonuclease H
activities [92]. +e screening of some plants showed anti-
retroviral activities. For instance, Ancistrocladus korupensis
[93] and Ancistrocladus congolensis [94] produced
michellamine A and B [95], Ancistrocladus congolensis [94].
4. Mechanisms of Action of Medicinal Plants
+e rare occurrence of infectious diseases in wild plants
serves as a fundamental indication of the presence of
competent defence mechanisms. Different mechanisms of
action through which phytochemicals can exert antimi-
crobial activities include (i) inhibition of the activity of
enzymes and toxins, (ii) damage of the bacterial membrane,
(iii) suppression of virulence factors, (iv) formation of
biofilm, (v) inhibition of protein synthesis, and (vi) quorum
quenching [96]. +e mode of action of tannins is based
majorly on their ability to bind proteins, thereby inhibiting
cell protein synthesis [97–99]. +e intervention of quorum
sensing is in three levels: (i) signal synthesis, (ii) signal
sequestration, and (iii) signal reception [100].
4.1. Synergistic Activity of AntimicrobialMedicinal Plants and
Antibiotics. Antibiotics have been effective in treating in-
fectious diseases, but resistance to these drugs has led to the
emergence of new and the reemergence of old infectious
diseases. +e development of resistance to antibiotics in
bacteria has been found possible due to three reasons: (i)
direct destruction or modification of the antibiotic by en-
zymes produced by the organism, (ii) modification of target
resulting in a reduction in the efficiency of binding of the
drug; and (iii) efflux of antibiotic from the cell [101–103].
One of the strategies used to overcome resistance
mechanisms in combination therapy includes combined
active drug or polyherbal formulations [10]. +e use of
natural products in combination with antibiotics to enhance
treatment efficacy is a new strategy developed to overcome
the problem of antibiotics resistance [104]. +e presence of
many bioactive compounds in a medicinal plant provides a
synergistic therapeutic effect, but when used simultaneously
with standard drugs, they often improve the activity of the
drug and will confront problems of toxicity and overdose
[13].
A combination of Helichrysum pedunculatum leaf extracts
with antibiotics used against wound infection associated bacteria
resulted in about 60% synergistic effect. Hemaiswarya et al. [105]
investigated the antiplasmodial activities of various combina-
tions of Murraya koenigii leaf, Artocarpus altilis stem bark [2],
Nauclea latifolia root, and Enantia chlorantha stem bark, with
standard drugs. +ey observed a significant reduction in the
protective, chemosuppressive, and curative actions ofN. latifolia
coadministered with standard drugs. Besides, N. latifolia or M.
koenigii in combination with other plants produced a synergistic
effect, unlike using each plant alone. Furthermore, E. chlorantha
with A. altilis or N. latifolia enhanced their respective pro-
phylactic or curative activities and served as promising com-
binations for the treatment of malaria [2]. Coadministration of
Carica papaya and Vernonia amygdalina plants in ameliorating
Plasmodium infection in mice showed synergistic effects with
significant percentage suppression of parasite load within three
days of clinical therapy [106].
5. Future of Medicinal Plants
+e future of medicinal plants is promising, considering the
vast number of medicinal plants that are yet to be selected
and investigated for their phytochemical compositions.
Medicinal plants have provided an avenue for under-
standing the scaffold for synthetic drug design and devel-
opment. In addition, the future of medicinal plants will
influence themedical practice, considering the occurrence of
new pathogens and diseases, which calls for alternative or
complementary medicine [11]. +e rising tide in antibiotic
resistance by microorganism has raised significant concern
in the medical field and, thus, an urgent demand for the
discovery of safe, natural compounds in this postgenomic
era. +e use of medicinal plants as nutraceuticals and
functional foods is on the increase, as means of ensuring
preventive medicine and finding a solution to this global
concern of evolution of drug-resistant microorganisms [1].
6. Conclusion
+is review report has revealed the efficacy of medicinal
plants as an alternative therapy in tackling the development
and spread of multidrug-resistant pathogens coupled with
the toxic effects of some antibiotics. However, this study
shows the lack of adequate characterization of the chemical
composition of the antimicrobial medicinal plants in
Nigeria. Only a few of the medicinal plants studied in
Nigeria have their bioactive components investigated using
advanced analyses such as GC-MS and HPLC. +e absence
of such analyses makes the claims from ethnomedicinal and
phytochemical screening studies invalidated. Due to enor-
mous therapeutic possibilities buried in the medicinal
plants, there is a need for research into unique fingerprints
and novel compounds that can provide cure to the neglected
tropical diseases (NTDs) endemic in Africa and especially in
Nigeria. Moreover, there is a need for innovative investi-
gation of novel natural bioactive compounds for the de-
velopment of chemical libraries useful for drug discovery
and development pipelines. A better understanding of the
underlying mechanism of the synergy of two or more
combinations of phytochemicals at a molecular level will
decrease the use of antibiotics and help to prevent and
overcome drug-resistant pathogens.
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